LEADER 04191nam 2200553 450 001 9910794934603321 005 20220812084121.0 010 $a2-7598-2149-8 024 7 $a10.1051/978-2-7598-2149-5 035 $a(CKB)4340000000201836 035 $a(MiAaPQ)EBC5024612 035 $a(Au-PeEL)EBL5024612 035 $a(CaPaEBR)ebr11436855 035 $a(OCoLC)1004190178 035 $a(DE-B1597)573269 035 $a(DE-B1597)9782759821495 035 $a(MiAaPQ)EBC6810295 035 $a(Au-PeEL)EBL6810295 035 $a(OCoLC)1287129054 035 $a(PPN)226414299 035 $a(EXLCZ)994340000000201836 100 $a20220812d2020 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aNuclear medicine $eradioactivity for diagnosis and therapy /$fRichard Zimmermann 205 $aSecond edition. 210 1$aLes Ulis :$cEDP Sciences,$d[2020] 210 4$dİ2020 215 $a1 online resource (216 pages) $cillustrations (some color) 311 $a2-7598-2140-4 320 $aIncludes bibliographical references. 327 $tFrontmatter -- $tDedication -- $tCONTENTS -- $tPreface -- $tIntroduction and Definitions -- $t1. Nuclear Medicine, What For? -- $t2. A Little History... -- $t3. Some Basic Notions of Radiation -- $t4. SPECT Imaging: Gamma Ray Imaging -- $t5. PET Imaging: Positron Emission Tomography -- $t6. Therapeutic Applications -- $t7. The Development of Radiopharmaceuticals -- $t8. The Production of Radiopharmaceuticals -- $t9. The Future of Nuclear Medicine -- $tGlossary -- $tFor Further Reading 330 $aNuclear medicine is a growing specialized medical field in which radiopharmaceuticals, i.e. drugs associated to radioactivity, are used for diagnostic or therapeutic purposes. Since 1942, nuclear medicine has progressed in such a way that it became a major diagnostic tool in hospitals. The past ten years have seen the introduction of major technical breakthroughs which will considerably modify the landscape of cancer treatment. Once injected to the patient, the radiopharmaceutical drug aims at the tumour cell ? including metastases ? selectively, settles there, and emits radiation. Depending on the radiation type, the drug will either help identify the cells or destroy them. Applications are not limited to oncology; indeed, nuclear medicine has found interesting applications in cardiology and neurology as well. The new millennium saw the introduction of the Hybrid imaging technology PET/CT which combines the Positron Emission Tomography (PET) modality with conventional high quality x-ray imaging. It took another two years until PET could be combined with Magnetic Resonance Imaging (MRI) in the hybrid equipment PET/MR. New tracers (drugs for diagnosis) also came on the market with different diseases as targets, such as prostate cancer, neuroendocrine tumours, or Alzheimer?s disease. But the recent introduction of radiotherapeutics in the treatment of cancer has brought major changes on the market, for they can be much more powerful and specific than chemotherapeutics or external radiation therapy. Combining radiodiagnostics to select positive responders to a treatment with efficient radiotherapeutics opens a highway for the development of theranostics, another word for personalized medicine. This scientific book aims to introduce nuclear medicine to a larger audience, pointing out, among other things, the difficulties met by both physicians and patients when trying to access new technologies. This second edition shows how much progress has been made over the past ten years since the original book was published, and how much can be expected for patients within the next few years. 606 $aNuclear medicine 606 $aNuclear medicine$xResearch 615 0$aNuclear medicine. 615 0$aNuclear medicine$xResearch. 676 $a616.0757 700 $aZimmermann$b Richard$f1956-$01106845 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910794934603321 996 $aNuclear medicine$93710898 997 $aUNINA